These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 32939208)
1. Neurolymphomatosis - Rare presentation in non-Hodgkin's lymphoma: The role of Fatima N; Zaman MU; Zaman A; Zaman SU World J Nucl Med; 2020; 19(2):159-161. PubMed ID: 32939208 [TBL] [Abstract][Full Text] [Related]
3. Neurolymphomatosis as a late relapse of non-Hodgkin's lymphoma detected by 18F-FDG PET/CT: a case report. Kajáry K; Molnár Z; Mikó I; Barsi P; Lengyel Z; Szakáll S Rev Esp Med Nucl Imagen Mol; 2014; 33(1):39-42. PubMed ID: 23683830 [TBL] [Abstract][Full Text] [Related]
4. An Extremely Rare Intersection: Neurolymphomatosis in a Patient with Burkitt Lymphoma Detected by 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. Oner AO; Okuyucu K; Alagoz E; Battal B; Arslan N World J Nucl Med; 2016 Sep; 15(3):209-11. PubMed ID: 27651745 [TBL] [Abstract][Full Text] [Related]
5. Secondary neurolymphomatosis of spinal nerve roots detected by ¹⁸F-FDG PET/CT: a case report and differential diagnosis of the case. Wang Y; Wang J; Jiang C; Peng Q; Wu M; Ma X Hell J Nucl Med; 2015; 18(3):261-3. PubMed ID: 26574697 [TBL] [Abstract][Full Text] [Related]
6. F-18 2-fluoro-2-deoxy-glucose positron emission tomography/computed tomography for the detection of radicular and peripheral neurolymphomatosis: correlation with magnetic resonance imaging and ultrasound. von Falck C; Rodt T; Joerdens S; Waldeck S; Kiesel H; Knapp WH; Galanski M Clin Nucl Med; 2009 Aug; 34(8):493-5. PubMed ID: 19617723 [TBL] [Abstract][Full Text] [Related]
7. Isolated Splenic Tuberculosis Masquerading as Disease Progression of Hodgkin's Lymphoma on Interim Dey S; Gupta N; Verma R; Seniaray N; Belho ES; Dhawan S Indian J Nucl Med; 2021; 36(1):100-102. PubMed ID: 34040315 [No Abstract] [Full Text] [Related]
8. The Diagnostic Dilemma of Neurolymphomatosis. Shree R; Goyal MK; Modi M; Gaspar BL; Radotra BD; Ahuja CK; Mittal BR; Prakash G J Clin Neurol; 2016 Jul; 12(3):274-81. PubMed ID: 27449910 [TBL] [Abstract][Full Text] [Related]
9. Neurolymphomatosis: a single-center experience of neuromuscular manifestations, treatments, and outcomes. Jeong J; Kim SW; Sung DH J Neurol; 2021 Mar; 268(3):851-859. PubMed ID: 33098033 [TBL] [Abstract][Full Text] [Related]
10. Neurolymphomatosis of multifocal peripheral nerve involvement: a case report. Peng L; Yang H; Zhao Y; He J; Stebbing J; Chen B Ann Palliat Med; 2022 Jul; 11(7):2529-2537. PubMed ID: 34670378 [TBL] [Abstract][Full Text] [Related]
11. Neurolymphomatosis in follicular lymphoma: an autopsy case report. Ando T; Kamoshita S; Riku Y; Ito A; Ozawa Y; Miyamura K; Fujino M; Ito M; Goto Y; Mano K; Akagi A; Miyahara H; Katsuno M; Yoshida M; Iwasaki Y Neuropathology; 2022 Aug; 42(4):295-301. PubMed ID: 35607714 [TBL] [Abstract][Full Text] [Related]
12. Computed tomography and 18F-FDG positron emission tomography for therapy control of Hodgkin's and non-Hodgkin's lymphoma patients: when do we really need FDG-PET? Reinhardt MJ; Herkel C; Altehoefer C; Finke J; Moser E Ann Oncol; 2005 Sep; 16(9):1524-9. PubMed ID: 15946979 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic Yield of FDG-PET/CT, MRI, and CSF Cytology in Non-Biopsiable Neurolymphomatosis as a Heralding Sign of Recurrent Non-Hodgkin's Lymphoma. Shaikh F; Chan AC; Awan O; Jerath N; Reddy C; Khan SA; Graham MM Cureus; 2015 Sep; 7(9):e319. PubMed ID: 26487995 [TBL] [Abstract][Full Text] [Related]
14. The role of 18F-FDG PET and 18F-FDG PET/CT in the evaluation of pediatric Hodgkin's lymphoma and non-Hodgkin's lymphoma. Qiu L; Chen Y; Wu J Hell J Nucl Med; 2013; 16(3):230-6. PubMed ID: 24137577 [TBL] [Abstract][Full Text] [Related]
15. The role of 18F-FDG PET/CT in Neurolymphomatosis: A Comprehensive Imaging Approach. Usmani S; Jain A; Riyami KA; Ahmed N; Al-Sukaiti R; Shamim MS J Pak Med Assoc; 2024 Apr; 74(4):822-824. PubMed ID: 38751291 [TBL] [Abstract][Full Text] [Related]
16. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging. Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400 [TBL] [Abstract][Full Text] [Related]
17. (18)F-FDG PET/CT in Neurolymphomatosis: Report of 3 Cases. Canh NX; Tan NV; Tung TT; Son NT; Maurea S Asia Ocean J Nucl Med Biol; 2014; 2(1):57-64. PubMed ID: 27408859 [TBL] [Abstract][Full Text] [Related]
18. Neurolymphomatosis on F-18 FDG PET/CT and MRI Findings: A Case Report. Hong CM; Lee SW; Lee HJ; Song BI; Kim HW; Kang S; Jeong SY; Ahn BC; Lee J; Chae YS Nucl Med Mol Imaging; 2011 Mar; 45(1):76-8. PubMed ID: 24899982 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of Öner AO; Sürer Budak E; Aydın F; Salim O; Yücel OK; Akkaya B; Toptaş T; Boz A; Yıldız A; Güngör F; Undar L Mol Imaging Radionucl Ther; 2017 Jun; 26(2):69-75. PubMed ID: 28613199 [TBL] [Abstract][Full Text] [Related]
20. Neurolymphomatosis--diagnosis and assessment of treatment response by FDG PET-CT. Lin M; Kilanowska J; Taper J; Chu J Hematol Oncol; 2008 Mar; 26(1):43-5. PubMed ID: 17957824 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]